Aortic Stenosis & TAVR: Updates from the ACC/AHA Valvular Heart Disease Guideline
This activity has been archived and credit is no longer available.
Dr. Jneid will provide an overview to Clinicians (case-based) about the diagnosis and management of AS from the ACC/AHA VHD Guidelines. To provide the clinicians with the perspectives of the American Guidelines pertinent to the treatment of AS and the recent recommendations related to TAVI and SAVR and contrast them w the recently published ESC guidelines. This recording has been made available from the Texas Heart Institute's Cardiology Grand Rounds series. CME credit is awarded from Texas Heart Institute.
Activity Information
This activity has been archived and credit is no longer available.
Needs Statement
Texas Heart Institute Cardiology Grand Rounds provides a weekly opportunity to learn from leading medical and surgical experts, sharing the latest advancements and innovations in the diagnosis, treatment, and prevention of cardiovascular disease. THI offers complimentary CME credits for participation in Grand Rounds On-Demand.
Educational Objectives
The intended result of this activity is increased knowledge. At the conclusion of this symposium, participants should be able to:
- Cite recommendations related to TAVI and SAVR, and contrast them w the recently published ESC guidelines.
- Summarize the indications and choices of treatment for AS, including TAVI and SAVR.
- Distinguish between the American and European Perspectives for the treatment of AS
Target Audience
Professional Categories
- Physicians
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
- Cardiology
- Family and Community Medicine
- Internal Medicine
- Thoracic Surgery
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Texas Heart Institute designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgement of Support
This continuing medical education activity has been supported in part by educational grants from the following company: Edward Lifesciences, LLC.
Activity Director
-
Stephanie Coulter, M.D., FACC, FASE
Clinical Instructor
Texas Heart Institute, Baylor College of Medicine
Term of Approval
April 21, 2022 through April 21, 2024.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Hani Jneid, M.D., FACC, FAHA, FSCAI
Associate Professor of Medicine, Director of Interventional Cardiology
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Activity Director
-
Stephanie Coulter, M.D., FACC, FASE
Clinical Instructor
Texas Heart Institute, Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: